Key facts
- This page summarizes Yeiseok Kim's Form 4 filing for OSR Health, Inc. (OSRH).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 19 Nov 2026, 08:43.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Additional SEC filing notes
Footnote F1
Represents shares of Common Stock issuable under the OSR Health, Inc. 2025 Omnibus Incentive Plan in settlement of accrued unpaid salary, at a price per share of $0.2272, equal to 115% of the volume-weighted average price of the Common Stock for the 15 trading days ended October 28, 2026. The award was approved by the Issuer's Board of Directors and Compensation Committee and is exempt under Rule 16b-3(d). The shares are subject to a six-month contractual lock-up from the grant date.